IL77322A - Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof - Google Patents

Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof

Info

Publication number
IL77322A
IL77322A IL77322A IL7732285A IL77322A IL 77322 A IL77322 A IL 77322A IL 77322 A IL77322 A IL 77322A IL 7732285 A IL7732285 A IL 7732285A IL 77322 A IL77322 A IL 77322A
Authority
IL
Israel
Prior art keywords
dimethylxanthine
processes
preparation
pharmaceutical compositions
sustained release
Prior art date
Application number
IL77322A
Other languages
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL77322A publication Critical patent/IL77322A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
IL77322A 1984-12-21 1985-12-13 Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof IL77322A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH611184 1984-12-21
CH268385 1985-06-24

Publications (1)

Publication Number Publication Date
IL77322A true IL77322A (en) 1990-07-12

Family

ID=25691137

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77322A IL77322A (en) 1984-12-21 1985-12-13 Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof

Country Status (20)

Country Link
US (1) US4803080A (fr)
EP (1) EP0185331B1 (fr)
KR (1) KR920006910B1 (fr)
CN (1) CN1008060B (fr)
AU (1) AU581274B2 (fr)
BG (1) BG60833B2 (fr)
CA (1) CA1261268A (fr)
CS (1) CS396391A3 (fr)
DE (1) DE3572924D1 (fr)
DK (1) DK164843C (fr)
ES (1) ES8704079A1 (fr)
FI (1) FI84782C (fr)
GR (1) GR853051B (fr)
HU (1) HU193359B (fr)
IE (1) IE58246B1 (fr)
IL (1) IL77322A (fr)
NO (1) NO171827C (fr)
NZ (1) NZ214534A (fr)
PT (1) PT81714B (fr)
SK (1) SK278868B6 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
EP0327295A3 (fr) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Forme de dosage de la tétracycline
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
AU2005325930B2 (en) * 2005-01-27 2012-01-19 Alembic Limited Extended release formulation of Levetiracetam
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
JP6158801B2 (ja) 2011-07-15 2017-07-05 ニューサート サイエンシーズ， インコーポレイテッド 代謝経路を変調させるための組成物および方法
CN108452311A (zh) 2012-11-13 2018-08-28 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
AU2014207707B2 (en) 2013-01-15 2018-11-01 Nusirt Sciences, Inc. Treating pulmonary conditions
AU2014236687A1 (en) 2013-03-15 2015-09-10 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
CA2939833A1 (fr) 2014-02-27 2015-09-03 Nusirt Sciences, Inc. Compositions et procedes permettant la reduction ou la prevention de steatose hepatique
EP3284795B1 (fr) * 2015-04-16 2023-08-02 The School Corporation Kansai University Utilisation d'un polymère contenant une base purique comme activateur anti-glaciogène
CN106176682A (zh) * 2016-08-30 2016-12-07 铜陵翔宇商贸有限公司 茶碱缓释制胶囊剂及其制备方法
WO2020067887A1 (fr) 2018-09-24 2020-04-02 Erasmus University Medical Center Rotterdam Inhibition spécifique de la janus kinase 3 (jak3) pour moduler des réponses immunitaires antitumorales
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
EP0083372B1 (fr) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Theophylline a liberation prolongee
US4587118A (en) * 1981-07-15 1986-05-06 Key Pharmaceuticals, Inc. Dry sustained release theophylline oral formulation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung

Also Published As

Publication number Publication date
DE3572924D1 (en) 1989-10-19
KR920006910B1 (ko) 1992-08-22
PT81714A (de) 1986-01-01
BG60833B2 (bg) 1996-04-30
SK278868B6 (sk) 1998-04-08
NO171827B (no) 1993-02-01
CS396391A3 (en) 1992-06-17
ES8704079A1 (es) 1987-04-01
PT81714B (pt) 1988-04-21
IE58246B1 (en) 1993-08-11
AU5161885A (en) 1986-07-17
DK164843C (da) 1993-01-11
KR860004634A (ko) 1986-07-11
NO171827C (no) 1993-05-12
ES550291A0 (es) 1987-04-01
CN85109688A (zh) 1986-06-10
US4803080A (en) 1989-02-07
FI84782C (fi) 1992-01-27
NZ214534A (en) 1988-08-30
CN1008060B (zh) 1990-05-23
GR853051B (fr) 1986-02-03
CA1261268A (fr) 1989-09-26
FI854973A0 (fi) 1985-12-16
DK600485D0 (da) 1985-12-20
DK164843B (da) 1992-08-31
AU581274B2 (en) 1989-02-16
NO855215L (no) 1986-06-23
FI854973A (fi) 1986-06-22
HU193359B (en) 1987-09-28
EP0185331A1 (fr) 1986-06-25
HUT40334A (en) 1986-12-28
IE853107L (en) 1986-06-21
EP0185331B1 (fr) 1989-09-13
FI84782B (fi) 1991-10-15
DK600485A (da) 1986-06-22

Similar Documents

Publication Publication Date Title
IL75400A0 (en) Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
IL87116A0 (en) 9-halogen-(z)-prostaglandin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0157346A3 (en) Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same
DE3563623D1 (en) Novel 1,5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
IL77322A (en) Sustained release pharmaceutical compositions containing 1,3-dimethylxanthine and processes for the preparation thereof
ZA89958B (en) Pharmaceutical compositions containing lactams,new substituted lactams and processes for the preparation thereof
IL84589A0 (en) Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
IL85290A0 (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation and pharmaceutical compositions containing same
IL84913A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
IL88903A0 (en) Indolylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
EP0168005A3 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
IL87563A0 (en) Isoxazole-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
ZA858195B (en) 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
IL76327A (en) Phenylacetonitrile derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
GB2179347B (en) Methylenedioxyphenanthrene and -stilbene derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ZA853375B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired